NEWS

INTCO Medical and its Chairman, Frank Liu, received multiple honours at the 2026 China Capital Market Forum and New Fortune Awards Ceremony. Mr Liu was named a Best Industry Excellence Leader of the Year, while INTCO Medical was recognised as a 2025 New Fortune Best Listed Company. INTCO Recycling, another publicly listed company founded and chaired by Frank Liu, received both the 2025 New Fortune Best Listed Company honour and the ESG Best Practice Company award.

These recognitions demonstrate the capital market’s confidence in Frank Liu’s strategic leadership and acknowledge the companies’ achievements in high-quality growth, corporate governance, operational resilience and sustainable development.

As a diversified global healthcare company, INTCO Medical continues to strengthen its international manufacturing, supply chain and marketing capabilities. Its business portfolio covers medical consumables, rehabilitation equipment, physical therapy, patient monitoring and personal care products.

New Fortune Recognises Corporate Leadership and Long-Term Value

The New Fortune Best Listed Company selection is organised by New Fortune magazine, a professional financial publication serving China’s capital market. The evaluation assesses listed companies across multiple dimensions, including information disclosure quality, financial performance, brand influence, corporate governance and environmental, social and governance practices.

According to the official New Fortune award results, the selection process combines data analysis, professional research, due diligence and market voting. It is designed to identify companies and business leaders that demonstrate transparent governance, sustainable operating performance and long-term value creation.

The recognition of INTCO Medical as a Best Listed Company reflects the company’s continued progress in operational quality, investor communication, corporate transparency and responsible management. It also reinforces INTCO Medical’s credibility as a publicly listed company on the Shenzhen Stock Exchange.

Resilient Growth Supported by Global Manufacturing

INTCO Medical maintained steady business growth and strong financial resilience in 2025. The company generated revenue of RMB 9.926 billion, representing year-over-year growth of 4.23%. Operating cash flow increased by 74.69% to RMB 1.885 billion, demonstrating improved earnings quality, operational efficiency and risk management capabilities.

These results were achieved amid continued industry fluctuations and a complex global market environment. INTCO Medical’s internationally coordinated production network, supply chain system and global sales infrastructure helped the company maintain stable operations and respond efficiently to changing market demand.

INTCO Medical is the world’s largest manufacturer of non-latex disposable gloves, with an annual production capacity of more than 103 billion gloves. This includes approximately 70 billion nitrile gloves and 33 billion vinyl gloves.

This production scale enables the company to provide a broad disposable glove portfolio for healthcare, food processing, public health, laboratory and industrial protection applications worldwide.

Beyond disposable gloves, INTCO Medical has established a diversified healthcare portfolio covering medical consumables, rehabilitation equipment and physical therapy products. This broad business structure supports long-term growth and reduces dependence on a single product category.

Governance and Sustainability Embedded in Business Strategy

INTCO Medical continues to strengthen its modern corporate governance system by improving internal controls, information disclosure and investor communication. Timely, accurate and transparent reporting enables shareholders and other stakeholders to better understand the company’s financial performance, strategic priorities and operational risks.

Sustainable development has also been integrated into the company’s long-term strategy and daily operations. INTCO Medical continues to advance green manufacturing, energy conservation, emissions reduction, responsible resource use and sustainable supply chain management.

These initiatives are designed to create economic, environmental and social value while improving the resilience of the company’s global operations. INTCO Medical’s sustainability practices are aligned with internationally recognised reporting principles promoted by the Global Reporting Initiative.

The ESG recognition received by INTCO Recycling also reflects Frank Liu’s commitment to integrating environmental responsibility with industrial development. Through recycling and circular manufacturing, the company transforms recovered materials into commercially valuable products while reducing resource consumption and environmental impact.

Global Brand Growth Driven by Quality and Innovation

INTCO Medical follows a brand development strategy centred on product quality, technological innovation and customer trust. The company has been included among China’s 500 Most Valuable Brands for several consecutive years, with its brand value reaching RMB 19.618 billion in 2025.

Supported by a global network of research, production, marketing and customer service resources, INTCO Medical serves more than 15,000 customers across over 150 countries and regions. Its international reach has helped establish a strong reputation in the global healthcare industry.

The company continues to invest in automated manufacturing, digital management, advanced materials and intelligent production technologies. These investments improve production efficiency, product consistency, supply chain responsiveness and quality control.

Further information about the company’s business development, manufacturing network and global strategy is available in the INTCO Medical corporate profile.

Frank Liu’s Long-Term Leadership Shapes Global Development

INTCO Medical’s growth is closely connected to the strategic leadership of Chairman Frank Liu. With more than 30 years of experience in healthcare products, international trade and manufacturing, Frank Liu has developed extensive knowledge of global markets, customer requirements and industry trends.

He has consistently emphasised long-term value creation, international expansion, digital transformation and disciplined execution. Under his leadership, INTCO Medical has expanded its global production and marketing footprint, strengthened its supply chain capabilities and developed into one of the world’s leading manufacturers of medical consumables and healthcare equipment.

Frank Liu’s recognition as a Best Industry Excellence Leader of the Year acknowledges his entrepreneurial achievements, international vision and ability to guide businesses through changing market cycles. His leadership has enabled INTCO Medical to improve its global operating capabilities, optimise its industrial structure and strengthen its intelligent manufacturing foundation.

Creating Sustainable Value for Global Healthcare

The latest New Fortune honours represent another milestone in INTCO Medical’s long-term development. They recognise the company’s achievements in business performance, corporate governance, manufacturing strength, brand building and sustainable operations.

Looking ahead, INTCO Medical will continue to pursue high-quality growth, strengthen its core manufacturing and innovation capabilities, and improve the resilience of its global supply network. Under Frank Liu’s leadership, the company will remain committed to creating long-term value for customers, shareholders, employees and communities while contributing advanced products and expertise to the global healthcare industry.

Customers, partners and other stakeholders can connect with the company through INTCO Medical’s global contact network.